Cargando…
Value of pre-treatment (18)F-FDG PET/CT radiomics in predicting the prognosis of stage III-IV colorectal cancer
BACKGROUND AND PURPOSE: To investigate the value of radiomics features extracted from pre-treatment (18)F-FDG PET/CT in predicting the outcomes of stage III-IV colorectal cancer (CRC), which may assist in clinical management strategies and precise treatment of stage III-IV CRC. MATERIALS AND METHODS...
Autores principales: | Wang, Na, Dai, Meng, Zhao, Yan, Zhang, Zhaoqi, Wang, Jianfang, Zhang, Jingmian, Wang, Yingchen, Liu, Yunuan, Jing, Fenglian, Zhao, Xinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941411/ https://www.ncbi.nlm.nih.gov/pubmed/36824703 http://dx.doi.org/10.1016/j.ejro.2023.100480 |
Ejemplares similares
-
Baseline (18)F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma
por: Jing, Fenglian, et al.
Publicado: (2023) -
(68)Ga-DOTATATE PET/CT imaging for insulinoma in MEN1 patient with endogenous hyperinsulinemic hypoglycemia: A case report
por: Liu, Yunuan, et al.
Publicado: (2022) -
Predicting PD-L1 expression status in patients with non-small cell lung cancer using [(18)F]FDG PET/CT radiomics
por: Zhao, Xiaoqian, et al.
Publicado: (2023) -
Case Report: (68)Ga-FAPI PET/CT, a more advantageous detection mean of gastric, peritoneal, and ovarian metastases from breast cancer
por: Li, Tianyue, et al.
Publicado: (2022) -
Pre-Clinical Study of the [(18)F]AlF-Labeled HER2 Affibody for Non-Invasive HER2 Detection in Gastric Cancer
por: Han, Jingya, et al.
Publicado: (2022)